185 related articles for article (PubMed ID: 27034160)
1. Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer.
An XZ; Zhao ZG; Luo YX; Zhang R; Tang XQ; Hao D; Zhao X; Lv X; Liu D
Oncotarget; 2016 Apr; 7(17):24719-33. PubMed ID: 27034160
[TBL] [Abstract][Full Text] [Related]
2. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
Sun Y; Peng W; He W; Luo M; Chang G; Shen J; Zhao X; Hu Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):166. PubMed ID: 30041673
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.
Masugi Y; Yamazaki K; Emoto K; Effendi K; Tsujikawa H; Kitago M; Itano O; Kitagawa Y; Sakamoto M
Lab Invest; 2015 Mar; 95(3):308-19. PubMed ID: 25599535
[TBL] [Abstract][Full Text] [Related]
4. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
[TBL] [Abstract][Full Text] [Related]
5. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
[TBL] [Abstract][Full Text] [Related]
6. Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway.
Meng X; Liu P; Wu Y; Liu X; Huang Y; Yu B; Han J; Jin H; Tan X
Bosn J Basic Med Sci; 2020 Feb; 20(1):106-116. PubMed ID: 31242404
[TBL] [Abstract][Full Text] [Related]
7. c-Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma.
You L; Ren X; Du Y; Zhao W; Cui M; Chen G; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3413-3420. PubMed ID: 27748943
[TBL] [Abstract][Full Text] [Related]
8. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
[TBL] [Abstract][Full Text] [Related]
9. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
10. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.
Baril P; Gangeswaran R; Mahon PC; Caulee K; Kocher HM; Harada T; Zhu M; Kalthoff H; Crnogorac-Jurcevic T; Lemoine NR
Oncogene; 2007 Mar; 26(14):2082-94. PubMed ID: 17043657
[TBL] [Abstract][Full Text] [Related]
11. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
Stalnecker CA; Grover KR; Edwards AC; Coleman MF; Yang R; DeLiberty JM; Papke B; Goodwin CM; Pierobon M; Petricoin EF; Gautam P; Wennerberg K; Cox AD; Der CJ; Hursting SD; Bryant KL
Cancer Res; 2022 Feb; 82(4):586-598. PubMed ID: 34921013
[TBL] [Abstract][Full Text] [Related]
13. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
[TBL] [Abstract][Full Text] [Related]
14. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
[TBL] [Abstract][Full Text] [Related]
15. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
[TBL] [Abstract][Full Text] [Related]
16. TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function.
Principe DR; Diaz AM; Torres C; Mangan RJ; DeCant B; McKinney R; Tsao MS; Lowy A; Munshi HG; Jung B; Grippo PJ
Oncogene; 2017 Jul; 36(30):4336-4348. PubMed ID: 28368414
[TBL] [Abstract][Full Text] [Related]
17. Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling.
Dudgeon C; Casabianca A; Harris C; Ogier C; Bellina M; Fiore S; Bernet A; Ducarouge B; Goldschneider D; Su X; Pitarresi J; Hezel A; De S; Narrow W; Soliman F; Shields C; Vendramini-Costa DB; Prela O; Wang L; Astsaturov I; Mehlen P; Carpizo DR
Cell Rep; 2023 Nov; 42(11):113369. PubMed ID: 37922311
[TBL] [Abstract][Full Text] [Related]
18. Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling.
Huyghe A; Furlan G; Ozmadenci D; Galonska C; Charlton J; Gaume X; Combémorel N; Riemenschneider C; Allègre N; Zhang J; Wajda P; Rama N; Vieugué P; Durand I; Brevet M; Gadot N; Imhof T; Merrill BJ; Koch M; Mehlen P; Chazaud C; Meissner A; Lavial F
Nat Cell Biol; 2020 Apr; 22(4):389-400. PubMed ID: 32231305
[TBL] [Abstract][Full Text] [Related]
19. Unraveling dedifferentiation and metastasis traces in pancreatic ductal adenocarcinoma ductal cells: Insights from single-cell RNA sequencing analysis of ITGB4 and C19orf33.
Asadzadeh Z; Hemmat N; Hassanian H; Alizadeh N; Mokhtarzadeh A; Jafarlou M; Baradaran B
Pathol Res Pract; 2024 Jan; 253():155012. PubMed ID: 38071887
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
